GSK3B and Alzheimer disease: It is worth noting that prolonged overexpression of GSK3b can deplete neurogenic niches, leading to the emergence of common AD symptoms such as Tau phosphorylation, amyloid‐β production, and synaptic dysfunction (Hernandez & Avila, 2008; Lauretti et al., 2020; Proctor & Gray, 2010).